Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
The Journal of Biological Chemistry|January 31, 2006
Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of BimJin-Ming Yang, Peter O'Neill, Wei Jin, et al.Oncotarget|July 23, 2016
A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent mannerSelina K Sutton, Daniel R Carter, Patrick Kim, et al.Proceedings of the National Academy of Sciences of the United States of America|November 14, 2023
Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasisDajiang Guo, Russell Jurek, Kimberley A Beaumont, et al.Frontiers in Oncology|February 7, 2022
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged LeukemiaMawar Karsa, Emma Ronca, Angelika Bongers, et al.Cell Systems|October 14, 2019
High-Content Imaging of Unbiased Chemical Perturbations Reveals that the Phenotypic Plasticity of the Actin Cytoskeleton Is ConstrainedNicole S Bryce, Tim W Failes, Justine R Stehn, et al.British Journal of Cancer|April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofinMawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.Cancers|April 3, 2021
Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine GliomaCaitlin Ung, Maria Tsoli, Jie Liu, et al.British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.Ebiomedicine|August 12, 2023
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsJérémy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, et al.Pageof 4